Clinical Trial Update: Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous unfractionated heparin after digital replantation and hand revascularization; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Amputation
• Traumatic Hand Injury

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Amputation; Traumatic, Hand | Phase 4 | Status: RECRUITING